136 related articles for article (PubMed ID: 37581749)
1. Addressing overdose risks and fatalities in public bathrooms: insights from the development of a Safer Bathroom Toolkit in British Columbia, Canada.
Gagnon M; Goodyear T; Riley S; Sedgemore KO; Leyland H
Can J Public Health; 2023 Dec; 114(6):934-942. PubMed ID: 37581749
[TBL] [Abstract][Full Text] [Related]
2. Overdose Prevention and Housing: a Qualitative Study Examining Drug Use, Overdose Risk, and Access to Safer Supply in Permanent Supportive Housing in Vancouver, Canada.
Ivsins A; MacKinnon L; Bowles JM; Slaunwhite A; Bardwell G
J Urban Health; 2022 Oct; 99(5):855-864. PubMed ID: 36044156
[TBL] [Abstract][Full Text] [Related]
3. Housing and overdose: an opportunity for the scale-up of overdose prevention interventions?
Bardwell G; Collins AB; McNeil R; Boyd J
Harm Reduct J; 2017 Dec; 14(1):77. PubMed ID: 29212507
[TBL] [Abstract][Full Text] [Related]
4. Convenience and comfort: reasons reported for using drugs alone among clients of harm reduction sites in British Columbia, Canada.
Papamihali K; Yoon M; Graham B; Karamouzian M; Slaunwhite AK; Tsang V; Young S; Buxton JA
Harm Reduct J; 2020 Nov; 17(1):90. PubMed ID: 33228676
[TBL] [Abstract][Full Text] [Related]
5. People who use drugs' prioritization of regulation amid decriminalization reforms in British Columbia, Canada: A qualitative study.
Xavier JC; McDermid J; Buxton J; Henderson I; Streukens A; Lamb J; Greer A
Int J Drug Policy; 2024 Mar; 125():104354. PubMed ID: 38402802
[TBL] [Abstract][Full Text] [Related]
6. Feeling safer: effectiveness, feasibility, and acceptability of continuous pulse oximetry for people who smoke opioids at overdose prevention services in British Columbia, Canada.
Moe J; Chavez T; Marr C; Cameron F; Feldman-Kiss D; Wang YE; Xavier JC; Mamdani Z; Purssell RA; Salmon A; Buxton JA
Harm Reduct J; 2024 Feb; 21(1):45. PubMed ID: 38378610
[TBL] [Abstract][Full Text] [Related]
7. Overdose deaths and the COVID-19 pandemic in British Columbia, Canada.
Palis H; Bélair MA; Hu K; Tu A; Buxton J; Slaunwhite A
Drug Alcohol Rev; 2022 May; 41(4):912-917. PubMed ID: 34908203
[TBL] [Abstract][Full Text] [Related]
8. British Columbia's Safer Opioid Supply Policy and Opioid Outcomes.
Nguyen HV; Mital S; Bugden S; McGinty EE
JAMA Intern Med; 2024 Mar; 184(3):256-264. PubMed ID: 38227344
[TBL] [Abstract][Full Text] [Related]
9. Opening Canada's first Health Canada-approved supervised consumption sites.
Patterson T; Bharmal A; Padhi S; Buchner C; Gibson E; Lee V
Can J Public Health; 2018 Aug; 109(4):581-584. PubMed ID: 30039262
[TBL] [Abstract][Full Text] [Related]
10. Identifying behaviours for survival and wellness among people who use methamphetamine with opioids in British Columbia: a qualitative study.
Corser J; Palis H; Fleury M; Lamb J; Lock K; McDougall J; Mehta A; Newman C; Spence H; Buxton JA
Harm Reduct J; 2022 May; 19(1):46. PubMed ID: 35590375
[TBL] [Abstract][Full Text] [Related]
11. Negative changes in illicit drug supply during COVID-19: Associations with use of overdose prevention and health services among women sex workers who use drugs (2020-2021).
Moreheart S; Shannon K; Krüsi A; McDermid J; Ettinger E; Braschel M; Goldenberg SM
Int J Drug Policy; 2023 Nov; 121():104212. PubMed ID: 37797570
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with obtaining prescribed safer supply among people accessing harm reduction services: findings from a cross-sectional survey.
Palis H; Haywood B; McDougall J; Xavier CG; Desai R; Tobias S; Burgess H; Ferguson M; Liu L; Kinniburgh B; Slaunwhite AK; Crabtree A; Buxton JA
Harm Reduct J; 2024 Jan; 21(1):5. PubMed ID: 38184576
[TBL] [Abstract][Full Text] [Related]
13. Implementation of pharmaceutical alternatives to a toxic drug supply in British Columbia: A mixed methods study.
Pauly BB; Kurz M; Dale LM; Macevicius C; Kalicum J; Pérez DG; McCall J; Urbanoski K; Barker B; Slaunwhite A; Lindsay M; Nosyk B
J Subst Use Addict Treat; 2024 Jun; 161():209341. PubMed ID: 38490334
[TBL] [Abstract][Full Text] [Related]
14. Motivations for concurrent use of uppers and downers among people who access harm reduction services in British Columbia, Canada: findings from the 2019 Harm Reduction Client Survey.
Steinberg A; Mehta A; Papamihali K; Lukac CD; Young S; Graham B; Lock K; Fleury M; Buxton JA
BMJ Open; 2022 May; 12(5):e060447. PubMed ID: 35501101
[TBL] [Abstract][Full Text] [Related]
15. Correlates of concurrent use of stimulants and opioids among people who access harm reduction services in British Columbia, Canada: Findings from the 2019 Harm Reduction Client Survey.
Lukac CD; Steinberg A; Papamihali K; Mehta A; Lock K; Buxton JA
Int J Drug Policy; 2022 Apr; 102():103602. PubMed ID: 35124412
[TBL] [Abstract][Full Text] [Related]
16. Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic.
Irvine MA; Kuo M; Buxton JA; Balshaw R; Otterstatter M; Macdougall L; Milloy MJ; Bharmal A; Henry B; Tyndall M; Coombs D; Gilbert M
Addiction; 2019 Sep; 114(9):1602-1613. PubMed ID: 31166621
[TBL] [Abstract][Full Text] [Related]
17. (Re)situating expertise in community-based overdose response: Insights from an ethnographic study of overdose prevention sites (OPS) in Vancouver, Canada.
Olding M; Boyd J; Kerr T; Fowler A; McNeil R
Int J Drug Policy; 2023 Jan; 111():103929. PubMed ID: 36529032
[TBL] [Abstract][Full Text] [Related]
18. Opioid prescribing practice standard in British Columbia, Canada: Rationale, controversies, and directions.
Lim J; McCracken RK; Panagiotoglou D
Int J Drug Policy; 2021 Nov; 97():103363. PubMed ID: 34314955
[TBL] [Abstract][Full Text] [Related]
19. "It's just a perfect storm": Exploring the consequences of the COVID-19 pandemic on overdose risk in British Columbia from the perspectives of people who use substances.
Foreman-Mackey A; Xavier J; Corser J; Fleury M; Lock K; Mehta A; Lamb J; McDougall J; Newman C; Buxton JA
BMC Public Health; 2023 Apr; 23(1):640. PubMed ID: 37013524
[TBL] [Abstract][Full Text] [Related]
20. The lessons learned from the fentanyl overdose crises in British Columbia, Canada.
Thomson E; Lampkin H; Maynard R; Karamouzian M; Jozaghi E
Addiction; 2017 Nov; 112(11):2068-2070. PubMed ID: 28901045
[No Abstract] [Full Text] [Related]
[Next] [New Search]
